Pharmaceutical pricing, cost containment and new treatments for rare diseases in children
نویسندگان
چکیده
Cost-containment in healthcare spending has become a central issue in public policy and healthcare reform, especially as the affordable care act adds millions of people to public and private insurance rolls. In this climate, longstanding criticism of pharmaceutical pricing has grown sharper, and many in both policy and medicine have characterized the costs of newly developed drugs as both exorbitant and wasteful of scarce healthcare resources. At the same time, pharmaceutical research and development pipeline costs are increasing exponentially.
منابع مشابه
Value Assessment and Pricing Frameworks for Rare Disease Treatments: New Approaches From The Literature.
• It has been 15 years since the introduction of orphan medicinal product (OMP) legislation in the EU. Until 2014, one hundred and twelve orphan drugs had been approved in Europe1. • Orphan drugs represent a particular challenge to payers due to the large unmet patient need, paucity of disease information and high per-patient costs2. As of yet, there is no consensus on the most appropriate fram...
متن کاملValue in Pharmaceutical Pricing
................................................................................................................................................... 8 RESUME ........................................................................................................................................................ 8 EXECUTIVE SUMMARY ......................................................................
متن کاملمقایسه نظام قیمت گذاری و بیمه دارو در ایران و کشورهای منتخب
Introduction: Pharmaceuticals comprise a large portion of health care expenditures, including insurance organizations expenditures. Accumulated evidence suggests that the inefficiencies of Iran's health insurance structure have led to soaring out- of- pocket payments by the beneficiaries of health insurance organizations. This study was conducted to compare pricing and reimbursement of pharmace...
متن کاملA New Approach for Accurate Pricing of Reactive Power and Its Application to Cost Allocation in Deregulated Electricity Markets
Reactive power management plays an essential role in the secure operation of the power system as an ancillary service. Although in electricity markets, the particular attention is paid to active power, the reactive power also plays an important on total generation costs of electricity. On the other hand, as it is mainly confined to local consumption, to avoid market power and maintain the se...
متن کاملNew workers' compensation legislation: expected pharmaceutical cost savings.
BACKGROUND California Workers' Compensation (WC) system costs are under review. With recently approved California State Assembly Bill (AB) 749 and Senate Bill (SB) 228, an assessment of proposed pharmaceutical cost savings is needed. METHODS A large workers' compensation database provided by the California Workers' Compensation Institute (CWCI) and Medi-Cal pharmacy costs obtained from the St...
متن کامل